Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine

Vaccine

Volumn 27, Issue 43, 2009, Pages 6095-6101

  Wu, Fan ^a   Yuan, Xiao Yi ^a   Huang, Wei Shan ^a   Chen, Ying Hua ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Combined vaccination; Heterosubtypic protection; Influenza virus; M2e; Split influenza vaccine

Indexed keywords

ALUMINUM; ANTIBODY; HEMAGGLUTININ INHIBITION ANTIBODY; INFLUENZA VACCINE; M2E ANTIBODY; M2E PEPTIDE; OIL; PEPTIDE DERIVATIVE; SPLIT INFLUENZA VACCINE; UNCLASSIFIED DRUG; WATER;

ADD ON THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EMULSION; FEMALE; IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MOUSE; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VIRAL MATRIX PROTEINS;

EID: 70349301940     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.037     Document Type: Article

References (21)

1. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305 5682 (2004) 371-376
2. Boni M.F. Vaccination and antigenic drift in influenza. Vaccine 26 Suppl 3 (2008) C8-C14
3. Kitler M.E., Gavinio P., and Lavanchy D. Influenza and the work of the World Health Organization. Vaccine 20 Suppl 2 (2002) S5-S14
4. Ungchusak K., Auewarakul P., Dowell S.F., Kitphati R., Auwanit W., Puthavathana P., et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352 4 (2005) 333-340
5. Poland G.A., and Sambhara S. Vaccines against influenza A (H5N1): evidence of progress. J Infect Dis 198 5 (2008) 629-631
6. Slepushkin V.A., Katz J.M., Black R.A., Gamble W.C., Rota P.A., and Cox N.J. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13 15 (1995) 1399-1402
7. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., and Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5 10 (1999) 1157-1163
8. Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., Heidecker G.J., et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22 23-24 (2004) 2993-3003
9. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 13 3 (2007) 426-435
10. Jegerlehner A., Schmitz N., Storni T., and Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172 9 (2004) 5598-5605
11. Wu F., Huang J.H., Yuan X.Y., Huang W.S., and Chen Y.H. Characterization of immunity induced by M2e of influenza virus. Vaccine 25 52 (2007) 8868-8873
12. Cottey R., Rowe C.A., and Bender B.S. Influenza Virus (2001), Wiley, New York
13. Cataldo D.M., and Van Nest G. The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice. Vaccine 15 16 (1997) 1710-1715
14. Nicholson KG WR, Hay A. Textbook of influenza. Oxford: Blackwell Science Ltd.; 1998.
15. Andreasen V., Viboud C., and Simonsen L. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 197 (2008) 270-278
16. Gioia C., Agrati C., Castilletti C., Capobianchi M., and Martini F. Influenza pandemics, immune cross-reactivity and pandemic control strategies. J Infect Dis 198 (2008) 294-295
17. Lamb R.A., Zebedee S.L., and Richardson C.D. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40 3 (1985) 627-633
18. Ernst W.A., Kim H.J., Tumpey T.M., Jansen A.D., Tai W., Cramer D.V., et al. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines. Vaccine 24 24 (2006) 5158-5168
19. Nguyen H.H., Moldoveanu Z., Novak M.J., van Ginkel F.W., Ban E., Kiyono H., et al. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 254 1 (1999) 50-60
20. Gioia C., Castilletti C., Tempestilli M., Piacentini P., Bordi L., Chiappini R., et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis 14 1 (2008) 121-128
21. Carragher D.M., Kaminski D.A., Moquin A., Hartson L., and Randall T.D. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol 181 6 (2008) 4168-4176